Immunotherapy Use in Newly Diagnosed NSCLC
EP. 1: Immunotherapy in NSCLC: An Update on Biomarkers
March 8th 2018
EP. 2: Frontline Immunotherapy in PD-L1+ NSCLC
March 8th 2018
EP. 3: Immunotherapy/Chemo Triplet in Frontline NSCLC
March 8th 2018
EP. 4: Choosing Among Frontline Options in NSCLC
March 8th 2018
EP. 5: NSCLC: Immunotherapy Toxicity Management
March 8th 2018
EP. 6: Quadruplet Therapy in NSCLC: IMpower150
March 8th 2018
EP. 7: NSCLC: Practical Considerations With Quadruplet Regimen
March 8th 2018
EP. 8: Dual Checkpoint Inhibition in NSCLC
March 8th 2018
EP. 9: Future Role of Immunotherapy in NSCLC
March 8th 2018
